A2a antagonists as cognition and motor function enhancers

• 收藏
• 分享

专利权人:

BIOTIE THERAPIES INC.

发明人:

Bandak, Stephen,Black, Kevin,Campbell, Meghan

申请号：

NZ74611811

公开号：

NZ746118A

申请日:

2011.11.04

申请国别(地区):

NZ

年份:

2020

代理人:

摘要：

Methods are described for inducing cognition and motor function enhancement in patients suffering from Parkinson’s disease by administering an effective amount of an Adenosine 2a antagonist such as 4-hydroxy-4-methylpiperidine-1-carboxylic acid-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide (TOZADENANT, SYN115). The Adenosine 2a antagonist can optionally be administered in combination with a dopamine precursor, such as levodopa, or a dopamine receptor agonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/